Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.05 USD
Change Today -0.05 / -2.38%
Volume 35.4K
As of 2:54 PM 10/8/15 All times are local (Market data is delayed by at least 15 minutes).

bovie medical corp (BVX) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/6/14 - $4.22
52 Week Low
09/30/15 - $1.72
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BOVIE MEDICAL CORP (BVX)

Related News

No related news articles were found.

bovie medical corp (BVX) Related Businessweek News

No Related Businessweek News Found

bovie medical corp (BVX) Details

Bovie Medical Corporation engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used in doctors’ offices, surgery centers, and hospitals worldwide. The company also develops J-Plasma, a patented plasma-based surgical tool that utilizes a helium ionization process to provide surgeons with greater precision, minimal invasiveness, and an absence of conductive currents during surgery. It leverages its expertise in the design, development, and manufacture of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing agreements. The company’s electrosurgical products include desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue. In addition, it offers electrosurgical disposables comprising Resistick II, a proprietary coating applied to stainless steel that resist eschar during surgery; and disposable laparoscopic electrodes for use by physicians from a group of specialties, including gynecology, general surgery, and urology. Further, the company provides battery operated cauteries for precise hemostasis in ophthalmology; specialty lighting instruments for use in ophthalmology, as well as distributes specialty lighting instruments; and a nerve locator stimulator primarily used for identifying motor nerves in hand and facial reconstructive surgery. It markets its electrosurgical products and technologies through both private labels and own brands, such as Bovie, Aaron, IDS, and ICON to distributors worldwide. The company was formerly known as An-Con Genetics Inc. and changed its name to Bovie Medical Corporation in October 1998. Bovie Medical Corporation is headquartered in Clearwater, Florida.

152 Employees
Last Reported Date: 02/27/15

bovie medical corp (BVX) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $525.5K
President, Chief Sales & Marketing Officer an...
Total Annual Compensation: $397.9K
Executive Chairman
Total Annual Compensation: $295.2K
Chief Commercialization Officer
Total Annual Compensation: $302.0K
Senior Vice President
Total Annual Compensation: $283.8K
Compensation as of Fiscal Year 2014.

bovie medical corp (BVX) Key Developments

Bovie Medical Corporation Signs GPO Agreement with Amerinet for J-Plasma

Bovie Medical Corporation announced that it has signed its first group purchasing organization (GPO) agreement with Amerinet for the use of J-Plasma by its members. The 3-year agreement with Amerinet, is in effect now through September 2018. Amerinet has more than 85,000 members, including 33,000 clinics, 3,500 acute care hospitals, and 3,300 ambulatory surgery centers. Through this agreement, Amerinet members will have access to J-Plasma, Bovie’s transformational surgical product, which enables surgeons to operate with greater precision and minimal thermal spread.

Bovie Medical Corporation Receives FDA 510(K) Approval for New J-Plasma® Pistol Grip Configurations

Bovie Medical Corporation announced that it has received FDA 510(k) approval for six new hand piece configurations that expand its J-Plasma pistol grip portfolio. The pistol grip hand piece will now be available with instrument lengths of 15cm, 33cm and 45cm, in addition to the existing length of 27cm. Also, these new length hand pieces will each be available with a new needle configuration, as well as the standard blade configuration. The new configurations have received FDA 510(k) approval and will be available beginning September 2015.

Bovie Medical Corporation Presents at Craig-Hallum Capital Group 6th Annual Alpha Select Conference, Sep-17-2015 12:00 PM

Bovie Medical Corporation Presents at Craig-Hallum Capital Group 6th Annual Alpha Select Conference, Sep-17-2015 12:00 PM. Venue: Convene Conference Center, 730 Third Avenue at 45th Street, New York, NY 10017, United States. Speakers: Robert L. Gershon, Chief Executive Officer and Director.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BVX:US $2.05 USD -0.05

BVX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
IRIDEX Corp $7.90 USD +0.07
MGC Diagnostics Corp $6.77 USD -0.24
Misonix Inc $10.51 USD +0.30
Stereotaxis Inc $1.04 USD +0.09
Utah Medical Products Inc $53.18 USD +0.20
View Industry Companies

Industry Analysis


Industry Average

Valuation BVX Industry Range
Price/Earnings 13.6x
Price/Sales 1.7x
Price/Book 2.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOVIE MEDICAL CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at